Variant report
Variant | esv1827302 |
---|---|
Chromosome Location | chr8:51225496-51246823 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:0)
- CpG islands (count:0)
- Chromatin interactive region (count:2)
- LncRNA region (count:0)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
No data |
No data |
(count:2 , 50 per page) page:
1
No data |
No data |
No data |
No data |
No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs528423937 | chr8:51236214-51236215 | Enhancers Active TSS | n/a | n/a | Overlapped CNVs | n/a |
2 | rs189452700 | chr8:51236222-51236223 | Enhancers Active TSS | n/a | n/a | Overlapped CNVs | n/a |
3 | rs559172393 | chr8:51236245-51236246 | Enhancers Active TSS | n/a | n/a | Overlapped CNVs | n/a |
4 | rs576788632 | chr8:51236272-51236273 | Enhancers Active TSS | n/a | n/a | Overlapped CNVs | n/a |
5 | rs537801099 | chr8:51236310-51236311 | Enhancers Active TSS | n/a | n/a | Overlapped CNVs | n/a |
6 | rs117809428 | chr8:51236333-51236334 | Enhancers Active TSS | n/a | n/a | Overlapped CNVs | n/a |
7 | rs537711211 | chr8:51236338-51236339 | Enhancers Active TSS | n/a | n/a | Overlapped CNVs | n/a |
8 | rs557687662 | chr8:51236365-51236366 | Enhancers Active TSS | n/a | n/a | Overlapped CNVs | n/a |
9 | rs71550226 | chr8:51236407-51236408 | Weak transcription Active TSS | n/a | n/a | Overlapped CNVs | n/a |
10 | rs71233484 | chr8:51236408-51236409 | Weak transcription Active TSS | n/a | n/a | Overlapped CNVs | n/a |
11 | rs397781043 | chr8:51236415-51236416 | Weak transcription Active TSS | n/a | n/a | Overlapped CNVs | n/a |
12 | rs11783674 | chr8:51236428-51236429 | Weak transcription Active TSS | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
13 | rs374332755 | chr8:51236433-51236434 | Weak transcription Active TSS | n/a | n/a | Overlapped CNVs | n/a |
14 | rs574242362 | chr8:51236475-51236476 | Weak transcription Active TSS | n/a | n/a | Overlapped CNVs | n/a |
15 | rs56890895 | chr8:51236478-51236479 | Weak transcription Active TSS | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
16 | rs564935352 | chr8:51236497-51236498 | Weak transcription Active TSS | n/a | n/a | Overlapped CNVs | n/a |
17 | rs560415351 | chr8:51236509-51236510 | Weak transcription Active TSS | n/a | n/a | Overlapped CNVs | n/a |
18 | rs572253833 | chr8:51236516-51236517 | Weak transcription Active TSS | n/a | n/a | Overlapped CNVs | n/a |
19 | rs545794377 | chr8:51236543-51236544 | Weak transcription Active TSS | n/a | n/a | Overlapped CNVs | n/a |
20 | rs28615617 | chr8:51236577-51236578 | Weak transcription Active TSS | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
21 | rs530385033 | chr8:51236585-51236586 | Weak transcription Active TSS | n/a | n/a | Overlapped CNVs | n/a |
22 | rs192873893 | chr8:51236628-51236629 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
23 | rs78807508 | chr8:51236671-51236672 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
24 | rs139619113 | chr8:51236685-51236686 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
25 | rs530179095 | chr8:51236713-51236714 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
26 | rs548263525 | chr8:51236730-51236731 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
27 | rs149615259 | chr8:51236735-51236736 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
28 | rs368270495 | chr8:51236760-51236761 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
29 | rs73579268 | chr8:51236761-51236762 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
30 | rs571085726 | chr8:51236763-51236764 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
31 | rs28640202 | chr8:51236819-51236820 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
32 | rs28546889 | chr8:51236862-51236863 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
33 | rs79707948 | chr8:51236868-51236869 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
34 | rs144316211 | chr8:51236890-51236891 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
35 | rs553868552 | chr8:51236911-51236912 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
36 | rs572291077 | chr8:51236918-51236919 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
37 | rs545933097 | chr8:51236927-51236928 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
38 | rs557774654 | chr8:51236944-51236945 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
39 | rs576324553 | chr8:51236950-51236951 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
40 | rs28814120 | chr8:51236954-51236955 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
41 | rs148801409 | chr8:51236960-51236961 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
42 | rs28845183 | chr8:51236967-51236968 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
43 | rs538990906 | chr8:51236979-51236980 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
44 | rs541942930 | chr8:51236980-51236981 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
45 | rs560166530 | chr8:51236995-51236996 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
46 | rs527892960 | chr8:51237007-51237008 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
47 | rs7462415 | chr8:51237012-51237013 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
48 | rs142442314 | chr8:51237013-51237014 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
49 | rs184120443 | chr8:51237023-51237024 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
50 | rs79349008 | chr8:51237024-51237025 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
Disease | PMID | Source |
---|---|---|
Cancer | 16751803 | CNVD |
Chronic lymphocytic leukemia | 21546498 | CNVD |
Wilms tumour | 21544195 | CNVD |
Gastric cancer | 17908304 | CNVD |
Melanoma | 18172304 | CNVD |
Medulloblastoma | 21979893 | CNVD |
Ewing''s sarcoma | 21437220 | CNVD |
Autism | 19415332 | CNVD |
Malaria | 21533027 | CNVD |
Non-syndromic sensorineural hearing loss | 22037309 | CNVD |
Esophageal cancer | 21851588 | CNVD |
Acute promyelocytic leukemia | 19109227 | CNVD |
Breast cancer | 21245420 | CNVD |
Thoracic aortic aneurysm | 21092924 | CNVD |
T-cell prolymphocytic leukemia | 19278963 | CNVD |
lymphocytic leukemia | 21291569 | CNVD |
Liver carcinoma | 19366792 | CNVD |
Hodgkin''s lymphoma | 17606441 | CNVD |
Seminomas | 18059402 | CNVD |
Autism | 22495311 | CNVD |
Acute lymphoblastic leukemia | 21390130 | CNVD |
Pancreatic cancer | 21811587 | CNVD |
Multiple myeloma | 16461302 | CNVD |
Developmental delay | 21373258 | CNVD |
Thyroid cancer | 19087340 | CNVD |
Myelofibrosis | 22110671 | CNVD |
Glioblastoma multiforme | 21080181 | CNVD |
Breast cancer | 17603634 | CNVD |
Pancreatic endocrine tumor | 17639061 | CNVD |
Disorders of sex development | 21048976 | CNVD |
Testicular cancer | 18059402 | CNVD |
Acute lymphoblastic leukemia | 22237106 | CNVD |
Salivary gland tumor | 18059337 | CNVD |
Breast cancer | 17133270 | CNVD |
Breast cancer | 21509527 | CNVD |
Acute myeloid leukemia | 20729466 | CNVD |
Breast cancer | 21858162 | CNVD |
Acute lymphoblastic leukemia | 20435627 | CNVD |
Acute lymphoblastic leukemia | 21248843 | CNVD |
Cancer | 20164919 | CNVD |
primary effusion lymphomas | 17116491 | CNVD |
Esophageal cancer | 20955586 | CNVD |
abnormal development | 18461090 | CNVD |
Cancer | 20164920 | CNVD |
low-grade B-cell lymphoma tumor | 18367492 | CNVD |
Oral cancer | 21386901 | CNVD |
Uveal melanoma | 21693616 | CNVD |
Langer-Giedion syndrome | 22283845 | CNVD |
Cancer | 21637783 | CNVD |
Splenic marginal zone lymphoma | 21957467 | CNVD |
Breast cancer | 20632083 | CNVD |
Breast cancer | 19602461 | CNVD |
Cancer | 22429812 | CNVD |
Endometrial cancer | 22040021 | CNVD |
Esophageal squamous carcinoma | 21637470 | CNVD |
Glioblastoma multiforme | 19960244 | CNVD |
Hepatocellular carcinoma | 22174799 | CNVD |
Oral cancer | 19627613 | CNVD |
Prostate cancer | 21088497 | CNVD |
colon cancer | 17210682 | CNVD |
Breast cancer | 21264507 | CNVD |
Breast cancer | 22028636 | CNVD |
Acute myeloid leukemia | 16864856 | CNVD |
Esophageal squamous carcinoma | 18350619 | CNVD |
Gastric cancer | 17167181 | CNVD |
Colorectal cancer | 19359472 | CNVD |
Breast cancer | 16461572 | CNVD |
Human rectal carcinomas | 16397240 | CNVD |
Medulloblastoma | 16968546 | CNVD |
head and neck squamous cell carcinoma | 18028549 | CNVD |
Breast cancer | 17001317 | CNVD |
Ewing''s sarcoma | 17952124 | CNVD |
Urothelial carcinoma | 21177765 | CNVD |
small cell lung cancer | 20016488 | CNVD |
Lung cancer | 18438408 | CNVD |
Acute myeloid leukemia | 21251322 | CNVD |
Glioblastoma multiforme | 22286061 | CNVD |
Prostate cancer | 16461572 | CNVD |
Breast cancer | 16608533 | CNVD |
Metanephric adenoma | 20802469 | CNVD |
Hepatocellular carcinoma | 18803288 | CNVD |
Melanoma | 17363583 | CNVD |
Prostate cancer | 18632612 | CNVD |
Glioblastoma multiforme | 18628472 | CNVD |
Sezary syndrome | 18413736 | CNVD |
Ovarian cancer | 22174824 | CNVD |
Non-syndromic sensorineural hearing loss | 17122850 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr8:51236200-51236400 | Enhancers | Ganglion Eminence derived primary cultured neurospheres | brain |
2 | chr8:51236200-51236600 | Active TSS | Fetal Heart | heart |
3 | chr8:51236400-51237800 | Weak transcription | Ganglion Eminence derived primary cultured neurospheres | brain |
4 | chr8:51238000-51238800 | Enhancers | Liver | Liver |
5 | chr8:51238800-51239000 | Flanking Active TSS | Liver | Liver |
6 | chr8:51239000-51239400 | Active TSS | Liver | Liver |
7 | chr8:51239400-51239800 | Flanking Active TSS | Liver | Liver |
8 | chr8:51239800-51241200 | Enhancers | Liver | Liver |
9 | chr8:51240200-51240800 | Enhancers | Mesenchymal Stem Cell Derived Adipocyte Cultured Cells | ES cell derived |
10 | chr8:51240800-51241200 | Active TSS | Mesenchymal Stem Cell Derived Adipocyte Cultured Cells | ES cell derived |
11 | chr8:51241000-51242600 | ZNF genes & repeats | Ganglion Eminence derived primary cultured neurospheres | brain |
12 | chr8:51241000-51243000 | ZNF genes & repeats | Cortex derived primary cultured neurospheres | brain |
13 | chr8:51241200-51241400 | Enhancers | Mesenchymal Stem Cell Derived Adipocyte Cultured Cells | ES cell derived |
14 | chr8:51241200-51241800 | Weak transcription | Liver | Liver |
15 | chr8:51241200-51242000 | ZNF genes & repeats | iPS-20b Cell Line | embryonic stem cell |
16 | chr8:51241400-51242400 | ZNF genes & repeats | H1 Cell Line | embryonic stem cell |
17 | chr8:51241800-51242000 | ZNF genes & repeats | Liver | Liver |
18 | chr8:51242000-51246800 | Weak transcription | Liver | Liver |
19 | chr8:51242400-51243200 | Weak transcription | H1 Cell Line | embryonic stem cell |
20 | chr8:51243200-51271600 | Weak transcription | Ganglion Eminence derived primary cultured neurospheres | brain |
21 | chr8:51246800-51247200 | Enhancers | Liver | Liver |